r-hCG

DRUG3 trials

Sponsors

Merck KGaA, Darmstadt, Germany, Dong-A Pharmaceutical Co., Ltd.

Conditions

Hyperovulation Induction for Assisted Reproduction TreatmentInfertilityOvarian Stimulation

Phase 2

Lutropin Alfa in Women at Risk of Poor Response

CompletedNCT01112358

Merck KGaA, Darmstadt, GermanyOvarian Stimulation

Start: 2005-12-07End: 2007-01-30Updated: 2018-08-28

Phase 3

A Study Using Recombinant Human Chorionic Gonadotrophin (rhCG, Ovidrel®) in the Induction of Final Follicle Maturation and Early Luteinization in Chinese Women Undergoing in Vitro Fertilization and Embryo Transfer (IVF/ET)

CompletedNCT01081756

Merck KGaA, Darmstadt, GermanyInfertility

Start: 2003-12-31End: 2004-09-30Updated: 2014-07-31

Clinical Trial Comparing the Efficacy and Safety of DA-3803 and Ovidrel

CompletedNCT01718119

Dong-A Pharmaceutical Co., Ltd.Hyperovulation Induction for Assisted Reproduction Treatment

Start: 2012-02-29Updated: 2013-08-13